baber/WOPTO huggingface dataset:
Patent NZ-511024-A (NZ)
Title: Methods for preventing/treating damage to sensory hair cells, loss of hearing and cochlear neurons using fused pyrrolocarbazoles
Inventor: YLIKOSKI JUKKA
IPC: A61K31/403
Filed: 1999-09-24
Abstract: Methods for preventing or treating damage to sensory hair cells and cochlear neurons are disclosed. The methods comprise the administration of an effective amount of a fused pyrrolocarbazole compound having the structure as shown in the specification. The method provides for the prevention/treatment of both hearing loss and loss of the sense of balance.
Patent NZ-514701-A (NZ)
Title: Bag with inner pouch and outer bag having tear strip with sufficiently high tack temperature
Inventor: FRASER STEPHEN CHARLES
IPC: B65D30/08
Filed: 2001-10-10
Abstract: A lie flat bag has an inner pouch and a protective outer block bottom bag. Intermediate bag layers are provided. A tear strip (not shown) is provided on a closure flap of the outer bag and has a tack temperature that is at least 20o C higher than a heat activated adhesive located on lapped surfaces of the bag.
Patent NZ-518031-A (NZ)
Title: Surgical retractor
Inventor: COHN WILLIAM
IPC: A61B46/23
Filed: 2000-09-29
Abstract: The present invention relates to a surgical retractor that immobilizes tissue at a surgical site. A preferred embodiment of the retractor is used during minimally invasive direct coronary bypass procedures to arrest movement of the grafting site while the heart continues pumping. Tape or thread can be used to connect the artery to the retractor with a holder.
Patent NZ-518957-A (NZ)
Title: Process for producing the tripeptides Ile-Pro-Pro and Val-Pro-Pro from milk casien with a peptidase and proteinase
Inventor: YAMAMOTO NAOYUKI
IPC: A61K38/00
Filed: 2000-11-10
Abstract: A method for producing a tripeptide to obtain at least one of tripeptides Val-Pro-Pro and Ile-Pro-Pro comprises digesting material containing milk casein with a proteinase to produce an intermediate peptide. The intermediate peptide is selected from the group consisting of a peptide containing a sequence Val-Pro-Pro but containing no other Prop other than in this sequence and a peptide containing a sequence Ile-Pro-Pro but containing no Pro other than those in this sequence and mixtures thereof. The intermediate peptide is then digested with a peptidase to produce at least one of tripeptides Val-Pro-Pro and Ile-Pro-Pro. The method may further comprise elevating the concentration of the intermediate peptide using a hydrophobic resin after digesting the material containing the milk casein with the proteinase and before performing digestion with the peptidase. The peptidase is preferably derived from the lactic acid bacteria Lactobacillus helveticus and the proteinase is preferably selected from papain, protease A, protease M or protease P
Patent NZ-519981-A (NZ)
Title: Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
Inventor: YAMAMOTO NOBORU
IPC: C07D409/12
Filed: 2001-01-18
Abstract: Nitrogenous cyclic compounds of formula (I) their salts, hydrates and pharmaceutical compositions containing the same are disclosed, wherein the variables shown therein are as defined in the specification. These compounds exhibit excellent calcium antagonism, particularly neuro-selective calcium antagonism.
Patent NZ-520569-A (NZ)
Title: Composition comprising water, a polyether nonionic emulsifier or an amine oxide emulsifier, an alkylaminophosphonic acid or a hydroxyalkylphosphonic acid or an alkylphosphonic acid carboxylic acid chelating agent, a mineral acid and a tetraalkylammonium surfactant
Inventor: KRAVITZ JOSEPH I
IPC: C11D3/06
Filed: 2001-03-07
Abstract: A  composition  suitable  for  removing  proteinaceous material   comprising  water,  an  emulsifier,  a  chelating agent, one or more mineral acids, and a surfactant; where: The  emulsifier  is a polyether nonionic  emulsifier  or  an amine oxide. The  chelating  agent  is  an alkylaminophosphonic  acid,  a hydroxyalkylphosphonic  acid,  or  an  alkylphosphonic  acid carboxylic acid. The  one or more mineral acids are present in an amount such that the pH of the composition is less than 4.5; and The surfactant is a compound of formula (I), where: R1,  R2,  and R3 are independently (C1-C6)alkyl,  where  any alkyl  group  can  be  substituted with  one  or  more  (C1- C6)alkoxy or hydroxy; R4 is represented by formula (a) or formula (b), where: R5  and  R6  are  independently  (C1-C6)alkylene  where  any alkylene  group  can be substituted with one  or  more  (C1- C6)alkoxy or hydroxy; R7  is  (C1-C6)alkylene  where the  alkylene  group  can  be substituted with one or more (C1-C6)alkoxy or hydroxy; q has an average value between 1 and 100; r has an average value between 1 and 100; and X is halo, RCOO -, PO42- or SO42- where R is (C1-C6)alkyl. Also  described  is  a  method  for  removing  proteinaceous material,   the  method  comprising  contacting  a   surface comprising  proteinaceous material with an effective  amount of  the  composition as described above and for an effective period of time to remove the proteinaceous material.
Patent NZ-522223-A (NZ)
Title: Method comprising the indirect electrochemical regeneration of NAD(P)H
Inventor: SCHMID ANDREAS
IPC: C25B3/25
Filed: 2001-05-16
Abstract: A method comprising the indirect electrochemical regeneration of NAD(P)H in enzymatic substrate conversions which are catalyzed by monooxygenases is described. In particular, a method for the electroenzymatic preparation of 2,3-dihydroxyphenyl derivatives, which is catalyzed by the enzyme 2-hydroxybiphenyl 3-monooxygenase and in which simultaneously the NAD+ formed by reductive cleavage of oxygen is electrochemically reduced, is described.
Patent NZ-522575-A (NZ)
Title: Techniques for investing in proxy assets
Inventor: WEISS ALLAN N
IPC: G06F17/00
Filed: 2001-05-09
Abstract: A proxy asset is a form of security which provides risk management capabilities, such as liquid interests in illiquid assets and economic indicators, without the deficiencies associated with other types of financial instruments. A proxy assets set is defined to respond to one or more indices. Each proxy asset has a share value and a number of shares. The proxy assets have a proxy assets set account value equal to a sum over all proxy assets of the products of the share value and the number of shares. The proxy asset set has a total number of shares equal to a sum over the proxy assets set of the number of proxy asset shares and has a proxy assets set account value equal to a sum over the proxy assets set of the proxy asset account value. The account value for the entire set of proxy assets is constrained by a value of a resources pool. The proxy asset account value is reevaluated according to the account formula upon occurrence of each event of a plurality of predetermined events. A system for providing a proxy asset set of two or more proxy assets that respond to a set of one or more indices comprises: A. a network; B. a computer readable medium connected to the network, the computer readable medium storing a value of a resources pool and a number of shares of each proxy asset for each investor of a set of investors; C. one or more bank processors connected to the network configured to compute the value of the resources pool; D. one or more proxy assets set processors configured for evaluating a proxy asset account value as a function of at least one corresponding index of the set of one or more indices, and for constraining the proxy assets set account value by the value of the resources pool and E. a set of rules for terminating at least some of the proxy asset shares and for distributing a corresponding amount from the resource pool in response to at least one trigger event. The indices can includes at least one of an index that represents one or more corporate stocks, mutual funds, proxy assets, or a composite index chosen from a group of indices derived from or comprising one or more of the 1) NASDAQ; 2) S & P 500 ; 3) Dow Jones Industrial Average; 4) NYSE Composite; and 5) Nikkei.
Patent NZ-526883-A (NZ)
Title: Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
Inventor: ARRHENIUS THOMAS
IPC: A61K31/425
Filed: 2002-02-19
Abstract: Compounds selected from the group consisting of compounds of formula (I) or (II), are disclosed. Pharmaceutical compositions comprising these compounds are also disclosed. The described compounds are useful, in the manufacture of a medicament for inhibiting malonyl CoA decarboxylase, in the manufacture of a medicament for shifting fatty acid metabolism to carbohydrate metabolism in a patient or, in the manufacture of a medicament for treating diseases or syndromes associated with fatty acid and glucose metabolism by increasing malonyl CoA concentration in a patient.
Patent NZ-527087-A (NZ)
Title: Type 2 cytokine receptor and nucleic acids encoding same
Inventor: FOUSER LYNETTE
IPC: A61K39/00
Filed: 2002-01-14
Abstract: Disclosed are isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides and pharmaceutical compositions comprising them. Also provided are antibodies that immunospecifically bind to a CRF2-12 polypeptide.
Patent NZ-528242-A (NZ)
Title: Method for processing and preserving food and processed food
Inventor: SAITO KASTUNORI
IPC: A23L3/40
Filed: 2002-04-02
Abstract: A method for processing and preserving foods includes a processing step of holding a seasoned food in a packaging member in a state in which the food by cold or frozen storage while maintaining the holding state. The packaging member can be a packaging bag and a container, and can be designed according the user's need. According to this method, it becomes possible to provide processed foods with superior freshness at a low cost.
Patent NZ-528699-A (NZ)
Title: Novel PRO703 polypeptides and nucleic acids wtih similarity to VLCAS ( very long chain acyl CoA synthase)
Inventor: WOOD WILLIAM I
IPC: C12N15/62
Filed: 1999-03-08
Abstract: An isolated nucleic acid having at least 80% sequence identity to a nucleotide sequence that encodes a polypeptide designated PRO703 comprising the amino acid sequence SEQ ID NO:102. Preferably the nucleic acid comprises the sequence of SEQ ID NO:101 or is that deposited under accession number ATCC 209706. Vectors, isolated host cells, processes for preparing the polypeptide and antibodies are also described. (62) Divided out of 507435
Patent NZ-529168-A (NZ)
Title: Preparation and isolation of indolocarbazole glycosides
Inventor: WEISSMAN STEVEN
IPC: C07H19/22
Filed: 2002-03-25
Abstract: Disclosed herein is a process to make indolocarbazole glycosides in high purity which inhibit the growth of tumor cells and are therefore useful in the treatment of cancer in mammals.
Patent NZ-530921-A (NZ)
Title: Milk powders for confectionery and bakery products
Inventor: SERIZAWA ATSUSHI
IPC: A21D2/26
Filed: 2002-08-01
Abstract: Disclosed are milk powders for confectionery and bakery products that, when added during the production of confectionery and bakery products, can increase the volume of breads, pancakes, cakes, pies, etc., and further add a desirable texture and feel in the mouth to breads, pancakes and cakes. Milk powders for confectionery and bakery products containing 4 to 10 weight-percent of non-protein nitrogen (based on the weight of converted protein) and 1 to 20 weight-percent of ash in a manner keeping the ratio of non-protein nitrogen to total nitrogen to 0.5 or less, are obtained by intermixing, as appropriate, dairy ingredients containing non-protein nitrogen with other dairy ingredients such as whole milk powders, skim milk powders, buttermilk powders, whey powders, milk minerals, whey protein concentrates and milk protein concentrates.
Patent NZ-538248-A (NZ)
Title: Crankshaft oil circuit
Inventor: ROTTER TERRENCE M
IPC: F16C3/14
Filed: 2003-07-14
Abstract: A crankshaft 220, and method for distributing lubricant along a crankshaft 220, are disclosed. The crankshaft 220 includes a crank pin 520, a crank arm 530, a main segment 510, and a flange 550. The crank arm 530 is coupled between the main segment 510 and the crank pin 520 and has an outer side 565. A channel 650 extends from within the crank pin 520 to the outer side 565. The flange 550 has outer 665 and inner edges 645, is positioned on the main segment 510 so that the outer edge 665 abuts the main segment 510, and is further positioned so the inner edge abuts the outer side of the crank arm 530. The flange 550 has first 630 and second grooves 640 along the outer 665 and inner edges 645 of the flange 550, respectively, and the grooves 630,640 form a passage extending from the channel 650 to an exterior portion of the main segment 510, so that lubricant can flow between the exterior portion of the main segment 510 and the channel 650 via the passage.
Patent NZ-538852-A (NZ)
Title: Selection and isolation of living cells using mRNA-binding probes
Inventor: SHEKDAR KAMBIZ
IPC: C12Q1/68
Filed: 2002-08-28
Abstract: A method for isolating cell expressing at least one RNA comprises: a) introducing into cells DNA encoding at least one RNA; b) exposing the cells to at least one molecular beacon that fluoresces upon hybridization to the RNA , wherein the molecular beacon comprises nucleotides complementary to the RNA; and c) isolating the cells that fluoresce. Preferably the cells are isolated using fluorescence activate cell sorter technology or fluorescence microscopy. Cells isolated by the method can be used to generate non-human transgenic animals and cell lines. Also described are proteolytic activity generating unitary hybridization probes.
Patent NZ-541155-A (NZ)
Title: Slot machine - pin and ball game
Inventor: BENNETT NICHOLAS
IPC: A63F13/10
Filed: 1999-11-24
Abstract: An electronic gaming console has credit means, reward means, game control means, display means and player input controls. The control means is responsive to the credit means and the player input controls to play a game which is displayed on the display means and if a wining event occurs, a player reward is awarded by the reward means. The game provides a game image on a video display of a labyrinth of pins and the player input controls allow the player to initiate the motion of ball images on the display and the player rewards are awarded when the ball images come to rest in predetermined prize winning locations. The game further comprises a chocolate wheel image which is activated by a ball contacting the wheel. The activation of the wheel results in one of a plurality of outcomes of the game. One of the outcomes is a prize being awarded to the player. (62) Divided Out of 530607
Patent NZ-541478-A (NZ)
Title: Admixture for fly ash concrete
Inventor: HILL RUSSELL
IPC: C04B14/00
Filed: 2004-01-22
Abstract: A method of reducing or eliminating the effect of fly ash or other combustible ashes on air entrainment in an air-entraining cementitious mixture is disclosed, which comprises the steps of: forming a cementitious mixture comprising water, cement, fly ash or another combustible ash, and an air entrainment agent, and entraining air in the mixture; wherein a sacrificial agent is also included in the cementitious mixture in at least the amount necessary to neutralize the detrimental effects of components of said fly ash or other combustible ash on air entrainment activity, the sacrificial agent comprising a material or mixture of materials that, when present in the same cementitious mixture without fly ash or the other combustible ash in said amount causes less than 2 vol.% additional air content in the cementitious mixture, wherein the sacrificial agent comprises an organic compound, with the proviso that said sacrificial agent does not comprise polyethylene glycol (PEG) or aromatic compounds having carboxylic acid groups, or salts thereof.
Patent NZ-545326-A (NZ)
Title: PPAR active compounds
Inventor: ARNOLD JAMES
IPC: C07D231/56
Filed: 2004-07-16
Abstract: Disclosed is a compound of formula I, wherein U, V, W, X and Y are all CR8, R2 is -S(O)2R21, n is 1, R1 is -C(O)OR or a carboxylic acid isostere, and the remaining substituents are as defined in the specification. The compounds are useful for the treatment of PPAR-mediated diseases or conditions such as obesity, hyperlipidemia, associated diabetic dyslipidemia, mixed dyslipidemia, hypoalphalipoproteinemia, Syndrome X, Type II diabetes mellitus, Type I diabetes, hyperinsulinemia, impaired glucose tolerance, insulin resistance, a diabetic complication of neuropathy, nephropathy, retinopathy or cataracts, hypertension, coronary heart disease, hypercholesterolemia, inflammation, thrombosis, congestive heart failure, cardiovascular disease, atherosclerosis, arteriosclerosis, hypertriglyceridemia, eczema, psoriasis, cancer, anorexia bulimia and anorexia nervosa.
Patent NZ-549605-A (NZ)
Title: Use of glufosfamide to treat chemotherapy-refractory pancreatic cancer
Inventor: TIDMARSH GEORGE
IPC: A61P35/00
Filed: 2005-02-04
Abstract: Disclosed is the use of glufosfamide for the manufacture of a medicament for use in the treatment of a chemotherapy-refractory pancreatic cancer, particularly a gemcitabine-refractory pancreatic cancer.
Patent NZ-552558-A (NZ)
Title: Compositions for delivering peptide YY and PYY agonists
Inventor: DINH STEVEN
IPC: A61K38/17
Filed: 2005-07-12
Abstract: Disclosed is a dosage unit form adapted for buccal administration comprising, (a) at least one peptide YY (PYY), a peptide YY agonist, or a mixture thereof, and (b) a delivery agent, of the formula (I) wherein the substituents are as described in the specification, and methods for its preparation. Also disclosed compositions can reduce nutrient uptake and are useful in the treatment of obesity.
Patent NZ-566746-A (NZ)
Title: Controlling a kiln using a drying schedule with adjustable step parameters
Inventor: WEIR GREGORY WARREN
IPC: F26B3/02
Filed: 2006-09-29
Abstract: Disclosed is a method of controlling a kiln for drying a charge of lumber. The method includes providing a drying schedule with sequential steps, monitoring conditions associated with the operation of the kiln, and advancing from one step to the next when determined by the schedule. During operation in each respective step kiln drying parameters are adjusted in accordance with changes to the monitored conditions to achieve the prescribed parameters for that step. Each step of the schedule provides for a plurality of different sets of prescribed parameters. The schedule provides for selection of the required set of parameters for the step, the parameters dependent on the monitored conditions and/or mode of kiln operation to influence moisture adsorption, absorption, or redistribution.
Patent NZ-566983-A (NZ)
Title: Fungicides and bioregulatory mixtures comprising epoxiconazole and trinexapac-ethyl
Inventor: SEMAR MARTIN
IPC: A01N37/42
Filed: 2006-09-29
Abstract: Disclosed is a fungicidal and bioregulatory mixture, comprising (1) epoxiconazole of the formula I, or salts or adducts thereof, and (2) trinexapac-ethyl of the formula II in a synergistically effective amount. Also disclosed is a method for controlling phytopathogenic harmful fungi, which comprises treating the harmful fungi, their habitat or the plants, the soil or seed to be protected against them with the above fungicidal mixture. Further disclosed is the use of the compounds I and II as defined above for preparing a composition suitable for controlling harmful fungi, and / or for regulating the growth of plants.
Patent NZ-567712-A (NZ)
Title: Compositions and methods for maintaining bone health or reducing bone loss
Inventor: SCHOLLUM LINDA MAY
IPC: A61K36/738
Filed: 2008-04-24
Abstract: Disclosed is the use of a water soluble extract of rosehip in the manufacture of a composition for treating or preventing a bone condition characterised by weakened or fragile bones e.g. osteoporosis.
Patent NZ-576248-A (NZ)
Title: Valve actuator for a container containing a pressurized fluid
Inventor: KRAEMER HANS
IPC: B65D83/14
Filed: 2007-10-18
Abstract: A valve actuator 10 for a container containing a pressurised fluid and having an operable valve via which the fluid is dispensed, comprises a mounting 11 attachable to the container, a control part 20 moveably mounted on the mounting, the control part 20 incorporating a valve operator 21 operably connectable to the valve when the mounting 11 is attached to the container, and incorporating an outlet conduit via which fluid may flow from the valve to an outlet opening, the control part 20 being moveable in a first direction to operate the valve to release fluid from the container, and being moveable in a second direction after use to thereby operate the valve to cease the flow of fluid, a variable volume post-expansion chamber 24 provided in communication with the outlet conduit via an expansion opening 27 and in which residual fluid remaining in the outlet conduit after use can expand, and a variable volume suction chamber 212 in communication with the outlet conduit via a suction opening which is more constricted relative to the flow of the fluid than is the expansion opening 27. The volume of the variable volume post expansion chamber 24 and the suction chamber 212 are reduced on movement of the control part 20 in the first direction and increased on movement of the control part 20 in the second direction such that the increase in volume of the suction chamber 212 creates an air pressure which is less than atmospheric. This reduced pressure is communicated via the suction opening to the outlet conduit to thereby suck residual fluid in the outlet conduit back from the outlet opening.
Patent NZ-576781-A (NZ)
Title: Novel amides acting on the adenosine receptors
Inventor: LUNDSTEDT TORBJORN
IPC: A61K38/05
Filed: 2007-11-09
Abstract: Disclosed are indole-phenyl amides as represented by the general formula (I), wherein R1 is an optionally substituted phenyl, benzyl or cyclohexyl group; Z is a saturated or unsaturated, straight or branched chain acyclic hydrocarbon group having 1 to 5 carbon atoms; R2 is selected from an amino, alkylamino, dialkylamino, or a guanidine group; and wherein the remaining substituents are as defined herein. Representative compounds include those such as 3-amino-N-[(4-bromo-phenyl)-cyclohexylcarbamoylmethyl]-N-[2-(1H-indol-3-yl)-ethyl]-propionamide, 3-amino-N-[benzylcarbamoyl-(2-bromo-phenyl)-methyl]-N-[2-(1H-indol-3-yl)-ethyl]-propionamide hydrochloride and N-[(2-chloro-4-fluoro-phenyl)-(4-fluoro-phenylcarbamoyl)-methyl]-N-[2-(6-fluoro-1H-indol-3-yl)-ethyl]-3-guanidino-propionamide. Further disclosed is a pharmaceutical composition which comprises a compound as defined above, together with one or more pharmaceutically acceptable adjuvants, carriers, diluents or excipients for the treatment of inflammation, arthritic conditions, rheumatoid arthritis, osteoarthritis, psoriatic arthritis, mental disorders, or for inducing central nerve regeneration.
Patent NZ-581044-A (NZ)
Title: A system adapted to enhancing the reading ability of a user with dyslexia
Inventor: KING PETER LAWRENCE
IPC: G09B13/04
Filed: 2009-11-10
Abstract: A system adapted to enhancing the reading ability of a user with dyslexia and a method for enhancing the reading ability of a user with dyslexia in conjunction with a computer application are disclosed. The system includes a processor means adapted to operate in accordance with the computer application. Also disclosed is the computer application adapted to enhance the reading ability of a user with dyslexia in conjunction with a computer. The application comprises (1) selection means adapted to select a portion of text, (2) speech processing means adapted to enable the portion of text to be spoken to the user, and (3) feedback means enabling the user to thereafter spell at least one word of the portion of text, by inputting at least one letter at a time and checking said input is correct.